首页> 外文期刊>Biochemistry and Biophysics Reports >Nitric oxide inhibits ATPase activity and induces resistance to topoisomerase II-poisons in human MCF-7 breast tumor cells
【24h】

Nitric oxide inhibits ATPase activity and induces resistance to topoisomerase II-poisons in human MCF-7 breast tumor cells

机译:一氧化氮抑制人MCF-7乳腺癌细胞中ATPase活性并诱导对拓扑异构酶II毒的抗性

获取原文
           

摘要

Background Topoisomerase poisons are important drugs for the management of human malignancies. Nitric oxide ( ? NO), a physiological signaling molecule, induces nitrosylation (or nitrosation) of many cellular proteins containing cysteine thiol groups, altering their cellular functions. Topoisomerases contain several thiol groups which are important for their activity and are also targets for nitrosation by nitric oxide. Methods Here, we have evaluated the roles of ? NO/ ? NO-derived species in the stability and activity of topo II (α and β) both in vitro and in human MCF-7 breast tumor cells. Furthermore, we have examined the effects of ? NO on the ATPase activity of topo II. Results Treatment of purified topo IIα and β with propylamine propylamine nonoate (PPNO), an NO donor, resulted in inhibition of the catalytic activity of topo II. Furthermore, PPNO significantly inhibited topo II-dependent ATP hydrolysis. ? NO-induced inhibition of these topo II (α and β) functions resulted in a decrease in cleavable complex formation in MCF-7 cells in the presence of m-AMSA and XK469 and induced significant resistance to both drugs in MCF-7 cells. Conclusion PPNO treatment resulted in the nitrosation of the topo II protein in MCF-7 cancer cells and inhibited both catalytic-, and ATPase activities of topo II. Furthermore, PPNO significantly affected the DNA damage and cytotoxicity of m-AMSA and XK469 in MCF-7 tumor cells. General significance As tumors express nitric oxide synthase and generate ? NO, inhibition of topo II functions by ? NO/ ? NO-derived species could render tumors resistant to certain topo II-poisons in the clinic. Highlights ? Nitric oxide ( ? NO) induces nitrosylation of many proteins, including topoisomerases. ? Nitrosation of topo II inhibited catalytic-, and ATPase activities of topo II. ? Inhibition of topo II activity resulted in resistance to topoisomerase II poisons.
机译:背景拓扑异构酶毒物是治疗人类恶性肿瘤的重要药物。一氧化氮(NO)是一种生理信号分子,可诱导许多含有半胱氨酸硫醇基团的细胞蛋白发生亚硝化作用(或亚硝化作用),从而改变其细胞功能。拓扑异构酶含有几个硫醇基团,这对于它们的活性很重要,也是一氧化氮亚硝化的目标。方法在这里,我们评估了?的作用。否/? NO衍生物种在体外和人MCF-7乳腺肿瘤细胞中topo II(α和β)的稳定性和活性。此外,我们研究了?的影响。 NO对拓扑II的ATPase活性。结果用NO供体丙胺丙胺壬酸酯(PPNO)处理纯化的topoIIα和β,会抑制topo II的催化活性。此外,PPNO明显抑制了topo II依赖的ATP水解。 ?在m-AMSA和XK469存在下,NO诱导的对这些topo II(α和β)功能的抑制导致MCF-7细胞中可裂解复合物的形成减少,并对MCF-7细胞中的这两种药物产生明显的耐药性。结论PPNO处理可导致MCF-7癌细胞中的topo II蛋白亚硝化,并抑制topo II的催化和ATPase活性。此外,PPNO显着影响MCF-7肿瘤细胞中m-AMSA和XK469的DNA损伤和细胞毒性。一般意义由于肿瘤表达一氧化氮合酶并产生?否,β抑制topo II功能。否/?在临床中,NO衍生的物种可能使肿瘤对某些topo II毒具有抗性。强调 ?一氧化氮(?NO)诱导许多蛋白质的亚硝基化,包括拓扑异构酶。 ?亚硝化的topo II抑制了topo II的催化和ATPase活性。 ?对topo II活性的抑制导致对topoisomerase II毒物的抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号